4-Methyl-3-nitrobenzenesulfonyl chloride → N-[5-chloro-2-(methylthio)phenyl]-4-methyl-3-nitrobenzenesulfonamide
Reaction equation
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([S:9][CH3:10])=[C:6]([NH2:8])[CH:7]=1.[CH3:11][C:12]1[CH:17]=[CH:16][C:15]([S:18](Cl)(=[O:20])=[O:19])=[CH:14][C:13]=1[N+:22]([O-:24])=[O:23]>>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([S:9][CH3:10])=[C:6]([NH:8][S:18]([C:15]2[CH:16]=[CH:17][C:12]([CH3:11])=[C:13]([N+:22]([O-:24])=[O:23])[CH:14]=2)(=[O:19])=[O:20])[CH:7]=1Participants
3
Procedure
Following General Procedure B, the title compound (197 mg, 61%) was prepared from 5-Chloro-2-methylsulfanyl-phenylamine (150 mg, 0.87 mmol) and 4-Methyl-3-nitro-benzenesulfonyl chloride (235 mg, 0.87 mmol).
Sources & evidence
- ORD record
- ord-1aa1c154a22d42e3a80c11a4003da803
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08450367B2
Reaction notes
Loading…